Free Trial

Benjamin Edwards Inc. Has $2.25 Million Holdings in CVS Health Co. (NYSE:CVS)

CVS Health logo with Retail/Wholesale background

Benjamin Edwards Inc. raised its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 548.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,837 shares of the pharmacy operator's stock after buying an additional 30,308 shares during the period. Benjamin Edwards Inc.'s holdings in CVS Health were worth $2,254,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the 3rd quarter valued at $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the 3rd quarter valued at about $32,000. Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $33,000. Finally, First Community Trust NA raised its holdings in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Piper Sandler decreased their price target on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Cantor Fitzgerald reissued a "neutral" rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Wells Fargo & Company raised shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Royal Bank of Canada cut their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Finally, Barclays lowered their target price on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $70.50.

View Our Latest Report on CVS

CVS Health Trading Down 2.0 %

Shares of CVS stock traded down $1.17 on Thursday, reaching $56.88. 9,062,721 shares of the stock were exchanged, compared to its average volume of 11,282,079. The stock has a 50 day moving average price of $59.43 and a 200 day moving average price of $58.81. The stock has a market cap of $71.58 billion, a PE ratio of 14.73, a P/E/G ratio of 1.01 and a beta of 0.54. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health's revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.21 earnings per share. Equities research analysts forecast that CVS Health Co. will post 5.37 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.68%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's payout ratio is 67.51%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

→ $19 for a FULL YEAR of stock picks?! (From Behind the Markets) (Ad)

Should you invest $1,000 in CVS Health right now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Energy Stocks Are Poised for Explosive Growth in 2025
From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines